Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Garden, Adam S."" wg kryterium: Autor


Tytuł :
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
Autorzy :
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lu C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Aug 06. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
Autorzy :
Diao K; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Nguyen TP; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Garden AS; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang CH; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Tung S; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang C; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Wang XA; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Lee A; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Spiotto MT; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Su SY; Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Phan J; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2021 Jul 16. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
Autorzy :
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Division of Cancer Medicine, Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
McCoy LA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; College of Medicine, University of Houston, Houston, Texas.
Sharafi CS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jones E; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas.
Steele K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Lai SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Corporate Authors :
MD Anderson Symptom Working Group
Źródło :
Cancer [Cancer] 2021 Jul 15; Vol. 127 (14), pp. 2453-2464. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
Autorzy :
Kish JA; H. Lee Moffitt Cancer Center & Research Institute, United States of America. Electronic address: .
Zhang Q; NRG Oncology Statistics and Data Management Center, United States of America.
Langer CJ; University of Pennsylvania, United States of America.
Nguyen-Tân PF; Centre Hospitalier de l'Université de Montréal-Notre Dame, Canada.
Rosenthal DI; University of Texas-MD Anderson Cancer Center, United States of America.
Weber RS; University of Texas-MD Anderson Cancer Center, United States of America.
List MA; University of Chicago Comprehensive Cancer Center, United States of America.
Wong SJ; Medical College of Wisconsin, United States of America.
Garden AS; University of Texas-MD Anderson Cancer Center, United States of America.
Hu K; New York University Langone, United States of America.
Trotti AM; H. Lee Moffitt Cancer Center & Research Institute, United States of America.
Bonner JA; University of Alabama at Birmingham, United States of America.
Jones CU; Radiological Associates of Sacramento, United States of America.
Yom SS; University of California San Francisco, United States of America.
Thorstad W; Washington University, United States of America.
Schultz CJ; Medical College of Wisconsin, United States of America.
Ridge JA; Fox Chase Cancer Center, United States of America.
Shenouda G; McGill University, Canada.
Harris J; NRG Oncology Statistics and Data Management Center, United States of America.
Le QT; Stanford University, United States of America.
Pokaż więcej
Źródło :
Journal of geriatric oncology [J Geriatr Oncol] 2021 Jul; Vol. 12 (6), pp. 937-944. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*
Head and Neck Neoplasms*/radiotherapy
Aged ; Humans ; Prognosis ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
Autorzy :
Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Duvall A; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston.
Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2021 Jul 01; Vol. 147 (7), pp. 615-623.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
Autorzy :
Cao J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States; Department of Radiation Oncology, The Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.
Zhang X; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Jiang B; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Chen J; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wang X; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wang L; Experimental Radiation Oncology, and The University of Texas MD Anderson Cancer Center, Houston, United States.
Sahoo N; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Zhu XR; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ye R; Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, United States.
Blanchard P; Department of Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France.
Garden AS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Fuller CD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Gunn GB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Frank SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jul; Vol. 160, pp. 32-39. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Oropharyngeal Neoplasms*/radiotherapy
Proton Therapy*/adverse effects
Radiotherapy, Intensity-Modulated*/adverse effects
Xerostomia*/epidemiology
Xerostomia*/etiology
Xerostomia*/prevention & control
Humans ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes.
Autorzy :
Hanania AN; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ausat N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna E; Department of Head and Neck Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 261-272. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer.
Autorzy :
Smith GL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fu S; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ning MS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nguyen DK; University of California Riverside School of Medicine, Riverside, CA, USA.
Busse PM; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Foote RL; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Rochester, MN, USA.
Garden AS; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mayo LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Snider JW 3rd; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Patel SH; Department of Radiation Oncology, Mayo Clinic and Mayo Clinic School of Medicine and Science, Phoenix, AZ, USA.
Katz SR; Willis-Knighton Proton Therapy Center, Shreveport, LA, USA.
Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Mohammed N; Northwestern Medicine Chicago Proton Center, Warrenville, IL, USA.
Dagan R; Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 319-327. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer.
Autorzy :
Bahig H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Centre Hospitalier de l'Université de Montréal, Montreal, Canada.
Gunn BG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ye R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ng SP; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peter MacCallum Cancer Center, Melbourne, Australia.
Gross ND; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 213-222. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience.
Autorzy :
Gunn GB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ye R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ausat N; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dahlstrom KR; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shah SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mayo LL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chun SG; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chronowski GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moreno AC; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Myers JN; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hanna EY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Esmaeli B; Ophthalmic Plastic Surgery, Department of Plastic Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison ML; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chambers MS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ginsberg LE; Department of Neuroradiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
El-Naggar AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhu XR; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 108-118. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life.
Autorzy :
Sherry AD; Vanderbilt University School of Medicine, Nashville, TN, USA.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sturgis EM; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gillison ML; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
El-Naggar AK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 234-247. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.
Autorzy :
Thaker NG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arizona Oncology, The US Oncology Network, Tucson, AZ, USA.
Boyce-Fappiano D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Guzman A; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Smith G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Holliday EB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Incalcaterra J; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shaitelman SF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Blanchard P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Feeley TW; Harvard Business School, Boston, MA, USA.
Kaplan RS; Harvard Business School, Boston, MA, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło :
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 374-382. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Autorzy :
Taku N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Wang L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Spiotto MT; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Chronowski G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Mayo LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ferrarotto R; Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhu XR; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. .
Pokaż więcej
Źródło :
Current treatment options in oncology [Curr Treat Options Oncol] 2021 Jun 04; Vol. 22 (6), pp. 54. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Autorzy :
Abdelmeguid AS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Teeramatwanich W; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Roberts DB; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Amit M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferraroto R; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Glisson BS; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kupferman ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Raza SM; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
DeMonte F; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Jun 01; Vol. 127 (11), pp. 1788-1795. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
Autorzy :
Grossberg AJ; Department of Radiation Medicine, Brenden Colson Center for Pancreatic Care, Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, USA. Electronic address: .
Rock CD; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Edwards J; School of Medicine, Oregon Health & Science University, Portland, USA.
Mohamed ASR; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Ruzensky D; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Currie A; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Rosemond P; Department of Clinical Nutrition, MD Anderson Cancer Center, Houston, USA.
Phan J; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Gunn GB; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Frank SJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Morrison WH; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Garden AS; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Fuller CD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA.
Rosenthal DI; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Jun; Vol. 159, pp. 21-27. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/metabolism
Head and Neck Neoplasms*/radiotherapy
Sarcopenia*/diagnosis
Sarcopenia*/etiology
Body Composition ; Body Mass Index ; Electric Impedance ; Female ; Humans ; Male ; Muscle, Skeletal
Czasopismo naukowe
Tytuł :
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
Autorzy :
Choi KY; Department of Otolaryngology Head and Neck Surgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, U.S.A.
Amit M; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Tam S; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Bell D; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Garden AS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Williams MD; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Ferrarotto R; Department of Thoracic, Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
El-Naggar AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Raza SM; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
DeMonte F; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Kupferman ME; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Hanna EY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Su SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2021 May; Vol. 131 (5), pp. E1468-E1475. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma/*diagnosis
Carcinoma, Neuroendocrine/*diagnosis
Diagnostic Errors/*statistics & numerical data
Maxillary Sinus Neoplasms/*diagnosis
Paranasal Sinus Neoplasms/*diagnosis
Paranasal Sinuses/*pathology
Sarcoma/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma/epidemiology ; Carcinoma/pathology ; Carcinoma/therapy ; Carcinoma, Neuroendocrine/epidemiology ; Carcinoma, Neuroendocrine/pathology ; Carcinoma, Neuroendocrine/therapy ; Child ; Child, Preschool ; Diagnostic Errors/prevention & control ; Female ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Maxillary Sinus Neoplasms/epidemiology ; Maxillary Sinus Neoplasms/pathology ; Maxillary Sinus Neoplasms/therapy ; Middle Aged ; Neoplasm Staging ; Paranasal Sinus Neoplasms/epidemiology ; Paranasal Sinus Neoplasms/pathology ; Paranasal Sinus Neoplasms/therapy ; Referral and Consultation/statistics & numerical data ; Retrospective Studies ; Sarcoma/epidemiology ; Sarcoma/pathology ; Sarcoma/therapy ; Young Adult
SCR Disease Name :
Sinonasal undifferentiated carcinoma
Czasopismo naukowe
Tytuł :
Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors.
Autorzy :
Aggarwal P; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.; University of Texas School of Public Health, Houston.
Goepfert RP; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Garg N; Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, Houston.
Zaveri JS; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Du XL; University of Texas School of Public Health, Houston.
Swartz MD; University of Texas School of Public Health, Houston.
Lai SY; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.
Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Ferrarotto R; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Piller LB; University of Texas School of Public Health, Houston.
Hutcheson KA; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston.; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston.
Pokaż więcej
Źródło :
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2021 May 01; Vol. 147 (5), pp. 469-478.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cranial Nerve Diseases/*epidemiology
Oropharyngeal Neoplasms/*therapy
Squamous Cell Carcinoma of Head and Neck/*therapy
Adult ; Aged ; Aged, 80 and over ; Cancer Survivors ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Risk Factors ; Texas/epidemiology
Czasopismo naukowe
Tytuł :
Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
Autorzy :
Dahlstrom KR; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Thall PF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; University of Texas Graduate School of Biomedical Sciences, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison WH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Cancer [Cancer] 2021 Apr 15; Vol. 127 (8), pp. 1228-1237. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.
Autorzy :
Stieb S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address: .
Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
He R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Zhu LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
McDonald BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Wahid K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ventura J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Ahmed S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
McCoy L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Deshpande TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Grant S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Apr; Vol. 157, pp. 63-69. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Head and Neck Neoplasms*/radiotherapy
Taste Buds*
Humans ; Mouth Mucosa ; Observer Variation ; Tongue
Czasopismo naukowe
Tytuł :
Generating High-Quality Lymph Node Clinical Target Volumes for Head and Neck Cancer Radiation Therapy Using a Fully Automated Deep Learning-Based Approach.
Autorzy :
Cardenas CE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Beadle BM; Department of Radiation Oncology, Stanford University, Palo Alto, California.
Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Skinner HD; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Yang J; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rhee DJ; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
McCarroll RE; Department of Radiation Oncology, University of Maryland Medical System, Baltimore, Maryland.
Netherton TJ; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gay SS; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Zhang L; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Court LE; Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Mar 01; Vol. 109 (3), pp. 801-812. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Tomography, X-Ray Computed*/methods
Deep Learning/*standards
Head and Neck Neoplasms/*diagnostic imaging
Lymph Nodes/*diagnostic imaging
Radiotherapy Planning, Computer-Assisted/*methods
Head and Neck Neoplasms/radiotherapy ; Humans ; Pharynx/diagnostic imaging ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies